Maurice Stroun

1926 - 2017

Maurice Stroun (1926–2017): The Architect of the Liquid Biopsy

In the mid-20th century, biological dogma held that DNA was a sedentary molecule, safely locked away within the nucleus of a cell. The idea that genetic material could leak out, circulate freely in the bloodstream, and travel between organisms was considered scientific heresy. Maurice Stroun, a Swiss biologist at the University of Geneva, spent his career challenging this dogma. Today, his once-marginalized theories form the bedrock of the "liquid biopsy"—a multi-billion-dollar industry that allows doctors to detect cancer and fetal genetic disorders through a simple blood draw.

1. Biography: A Life in Geneva

Maurice Stroun was born on December 11, 1926, in Geneva, Switzerland. He spent the vast majority of his academic life at the University of Geneva, an institution that would become the epicenter of a quiet revolution in molecular biology.

Stroun earned his doctorate in 1956, specializing in plant physiology. His early career was spent navigating the intricate world of botanical genetics, but his curiosity soon drifted toward the mechanisms of how DNA behaves outside the traditional boundaries of the cell. He rose through the ranks at the University of Geneva, eventually becoming a professor and leading a research group that would be colloquially known as the "Geneva Group."

Despite the global implications of his work, Stroun remained a quintessential European academic—focused, persistent, and deeply collaborative. He passed away on March 1, 2017, living long enough to see his "impossible" theories become standard medical practice.

2. Major Contributions: The Circulating Nucleic Acid Revolution

Stroun’s primary contribution to science was the discovery and characterization of extracellular DNA and RNA.

Challenging the "Cell-Locked" Dogma: While French researchers Mandel and Metais had observed DNA in plasma as early as 1948, their work was largely ignored. Stroun was the first to provide a functional context for this phenomenon. He proposed that living cells actively secrete DNA into the extracellular environment.
The "Stroun Effect": He demonstrated that DNA could be transferred between different types of organisms (such as bacteria and plants) through a process of spontaneous uptake. This suggested that horizontal gene transfer was more common than previously thought.
Circulating Tumor DNA (ctDNA): In the 1970s and 80s, Stroun and his colleague Philippe Anker made the radical claim that the blood of cancer patients contained DNA fragments carrying the same genetic mutations as their tumors. This meant that a blood test could, in theory, replace a surgical tissue biopsy.
Active Secretion Theory: Stroun argued that circulating DNA was not just the "debris" of dead cells (necrosis), but was actively released by healthy and malignant cells alike to potentially act as a messenger molecule.

3. Notable Publications

Stroun’s bibliography tracks the evolution of molecular biology from the study of plants to human oncology.

Bacterial RNA synthesis in frog auricles after intraperitoneal injection of bacteria (1971, Nature): An early, provocative study exploring how foreign genetic material interacts with a host.
Exogenous DNA transcription in cells of animals and plants (1977, International Review of Cytology): A comprehensive summary of his early work on how cells take up and use "outside" DNA.
Isolation and characterization of DNA from the plasma of cancer patients (1987, Cancer Research): This is arguably his most influential paper. It provided definitive evidence that the DNA found in the blood of cancer patients possessed the characteristics of tumor DNA, laying the groundwork for modern oncology.
The Origin and Mechanism of Circulating DNA (2000, Annals of the New York Academy of Sciences): A late-career synthesis of his life’s work, detailing how cells actively secrete nucleic acids.

4. Awards and Recognition

For decades, Stroun worked in relative obscurity because his findings were so far ahead of the technology required to use them. However, as DNA sequencing technology (PCR and NGS) caught up in the late 1990s, the world took notice.

Prix de la Ville de Genève (2001): Awarded for his contributions to the biological sciences.
Founding of ISCN: He was a foundational figure in the International Society of Circulating Nucleic Acids (ISCN), which now hosts major global symposiums on liquid biopsies.
Posthumous Acclaim: While he did not receive a Nobel Prize, he is widely cited in the Nobel-caliber research of others (such as Dennis Lo, who applied Stroun’s principles to prenatal testing).

5. Impact and Legacy

Maurice Stroun is often called the "Father of Circulating Nucleic Acids." His legacy is visible in two primary fields:

Non-Invasive Prenatal Testing (NIPT): Every year, millions of pregnant women undergo blood tests to screen for Down syndrome and other genetic conditions. These tests work by detecting fetal DNA circulating in the mother’s blood—a direct application of Stroun’s discovery that DNA crosses biological barriers and circulates freely.
Oncology and "Liquid Biopsies": Modern cancer treatment relies on monitoring "minimal residual disease" through blood tests. Companies like Grail and Guardant Health, valued at billions of dollars, exist because Stroun proved that a tumor’s genetic "signature" is present in the blood.
The Shift in Biology: He helped shift the view of DNA from a static blueprint to a dynamic, communicative molecule that exists both inside and outside the cell.

6. Collaborations

Stroun’s work was rarely a solo endeavor. His most significant partnership was with Philippe Anker, a fellow researcher at the University of Geneva. For over 40 years, the names "Stroun and Anker" appeared together on nearly every major paper in the field.

He also collaborated extensively with Pierre Gahan (King’s College London), who helped bridge the gap between plant physiology and human pathology. This "Geneva Group" was instrumental in keeping the flame of extracellular DNA research alive during the 1970s and 80s when the rest of the scientific community was skeptical.

7. Lesser-Known Facts

The "Contamination" Dismissal: When Stroun first published his findings on DNA in the blood, many peers dismissed his results as "laboratory contamination." It was simply inconceivable at the time that DNA could survive the enzymes in the blood (nucleases). Stroun had to prove that the DNA was protected, often by being bound to proteins or lipids.
From Plants to Humans: Stroun's transition from plant biology to human medicine is a rare example of "trans-disciplinary" success. He began by looking at how plants take up DNA from the soil and wondered if the same principles applied to the human bloodstream.
A Scientific Prophet: It took nearly 20 years for his 1987 paper on cancer DNA to be fully appreciated. It wasn't until the mid-2000s that technology became sensitive enough to routinely detect the tiny amounts of DNA Stroun had identified decades earlier.

Maurice Stroun’s career serves as a testament to the power of persistence. By looking where others were not, and by refusing to accept that the cell was a closed system, he unlocked a new dimension of medical diagnostics that continues to save lives today.